US FDA asks fired scientists to return, including some reviewing Musk’s Neuralink
The U.S. Food and Drug Administration is asking some of its recently fired scientists if they will come back to their jobs, ...
FDA and USDA among federal agencies aiming to rehire workers hit by mass firings
A number of agencies are looking to rehire federal workers who lost their jobs as part of the Trump administration's mission ...
Trump Administration Reverses Layoffs At These Federal Agencies—After Cutting Bird Flu, FDA Staff
Some employees at the National Nuclear Security Administration, which oversees the U.S.’ nuclear weapons, were reportedly ...
FDA says Ozempic shortage is over, chilling boom in off-brand versions
The FDA has now resolved the shortages of Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs, which could spell the ...
Smokescreen: some vape firms pivot after FDA crackdown
Some e-cigarette companies targeted by U.S. authorities have altered their business model or changed their corporate ...
Pharm Exec2h
FDA Accepts Supplemental New Drug Application for Teva, Medincell’s Uzedy for Bipolar I Disorder
The application leverages existing clinical data for Uzedy along with prior FDA findings on the safety of Udezy in patients ...
Former FDA chief ‘very concerned’ about Texas measles outbreak spreading
Commissioner Dr. Scott Gottlieb said he is “very concerned” about the measles outbreak in Texas spreading. Gottlieb joined ...
manilatimes2d
United States FDA Approves NM8074 (Ruxoprubart) IND for Treating Dermatomyositis (DM): A Chronic Inflammatory Disorder of the Skin
DM is an immune-mediated myopathy characterized by chronic inflammation of the skin and muscles, progressive muscle weakness, and potential involvement of internal organs. The role of complement ...
Shortage of popular drugs Wegovy and Ozempic is over, FDA says.
The FDA said the shortage of Novo Nordisk's weight-loss drugs Wegovy and Ozempic is resolved. The move could limit cheaper compounded versions ...
FDA Grants Fast-Track Designation To Cannabis Withdrawal Syndrome Drug
U.S.-based PleoPharma announced yesterday that the FDA has granted it a fast-track designation for PP-01, a new ...
manilatimes20h
FDA Accepts BLA for TLX250-CDx (Zircaix®) for Kidney Cancer Imaging, Grants Priority Review
Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the United States (U.S.) Food ...
medtechdive6d
Device industry scrambles as FDA job cuts cause delays
The cuts at the FDA’s device center could add “months, if not years” to the time it takes to bring products to market, an ...